Emerging research suggest Retatru tide , a dual activator targeting both GLP-1 and another hormone, could offer a promising development for body management . Early human tests have demonstrated substantial losses in visceral tissue, possibly outperforming current weight-loss medications . Nevertheless , more assessment is necessary to completely de